Acta Scientific Clinical Oncology (ASCO)

Acta Scientific Clinical Oncology (ASCO) is an international, double- blinded peer-reviewed, highly viewed open access journal with a good impact factor that invites contributions of original and novel fundamental research on all aspects of developments of types of malignancies including pathology, diagnosis and therapy, including radiotherapy, and systemic treatment. We welcome you to submit your complete, valuable and reliable articles towards the journal at editor@actascientific.com

Acta Scientific Clinical Oncology (ASCO) is :-

• International, Peer-Reviewed, Open Access, Refereed, radiotherapy, Clinical Oncology, Cancer, Bladder Cancer, Brain Cancer, Breast Cancer, Colorectal Cancer, Genomic Cancer, Head and Neck cancer, HPV and Cervical Cancer, Lung Cancer, Liver Cancer, Melanoma, Metastatic Breast Cancer, Non-colorectal Gastrointestinal Cancer, Prostate Cancer, Renal Cell Carcinoma, Skin Cancer, Testicular cancer, Ovarian Cancer, Benign tumours, Cancer Chemotherapy, Pediatric oncology, Cancer prevention, Recent developments in tumor therapy, Radiation oncology, Veterinary and Comparative oncology, Clinical trials in oncology, Cancer nanotechnology, Carcinoma, Sarcoma, Myeloma, Leukemia, Lymphoma, Osteosarcoma or Osteogenic sarcoma, Chondrosarcoma, Leiomyosarcoma, Rhabdomyosarcoma, Mesothelial sarcoma or mesothelioma, Fibrosarcoma, Angiosarcoma, Liposarcoma, Glioma or Astrocytoma, Mesenchymous or Mixed mesodermal tumor, Genomic Medicine, Haematology , Online , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: issn in waiting 3, Established: 2019,
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE